Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nightingale Health Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €203.35M | -11.4x | -3.5 | €3.31 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11.9% Downside | Upgrade to Pro+ | |
Faron Pharmaceuticals Oy | Helsinki | Healthcare | Biotechnology & Medical Research | €199.76M | -4.2x | -1.11 | €1.88 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.9% Upside | Upgrade to Pro+ | |
Solar Foods Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €122.59M | €4.97 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Nanoform Finland Plc | Helsinki | Healthcare | Biotechnology & Medical Research | €104.52M | -6.7x | -8.02 | €1.23 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Herantis Pharma Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €28.12M | -42.3x | -0.52 | €1.39 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |